Iktos alternatives and competitors
The closest alternatives to Iktos are Variational AI, Insilico Medicine, Genesis Molecular AI and Numerion Labs.
Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016.
10 alternatives to Iktos
What each product does, with its price as the vendor publishes it.
-
V
Variational AI develops Enki, a generative model for designing small molecules against a research team's target product profile.
Price: Custom project pricing
-
I
Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines.
Price: No published price
-
G
Stanford spinout, now trading as Genesis Molecular AI, building GEMS, a small molecule discovery platform its own chemists and its partners' programs run on.
Price: No published price
-
N
Numerion Labs, formerly known as Atomwise, is a San Francisco AI drug discovery company developing small molecules for immune and inflammatory disease, led by chief executive Steve Worland.
Price: No published price
-
P
PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to decide what to make, PostEra builds models of how to make it.
Price: No published price
-
A
Aqemia designs small molecule drug candidates with Qemi, a platform that joins physics based prediction of how tightly a molecule binds its target with generative AI that proposes new molecules.
Price: No published price
-
S
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Price: No published price
-
I
Clinical stage drug discovery company in San Diego whose platform pairs two named model families with automated laboratories.
-
R
Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning foundation models trained on the resulting 50 petabyte plus dataset of cellular images…
Price: Not applicable
-
X
XtalPi is a drug and materials discovery company founded in Boston in 2015 by three MIT postdoctoral physicists, headquartered in Shenzhen and listed on the Hong Kong Stock Exchange (2228) since 2024.
Price: No published price
Iktos alternatives, answered
What are the best alternatives to Iktos?
The closest alternatives to Iktos are Variational AI, Insilico Medicine, Genesis Molecular AI, Numerion Labs and PostEra. Variational AI develops Enki, a generative model for designing small molecules against a research team's target product profile. Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines. Stanford spinout, now trading as Genesis Molecular AI, building GEMS, a small molecule discovery platform its own chemists and its partners' programs run on.
Who are Iktos's competitors?
Iktos's competitors in the Drug Discovery AI category include Variational AI, Insilico Medicine, Genesis Molecular AI, Numerion Labs, PostEra and Aqemia.